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Authors’ reply
We thank Dr Roerdink and Dr Dietvorst for their
insightful comments on our study (1). One concern
was that we did not differentiate between native joint
infections and periprosthetic joint infections (PJIs).
Because the pathology, treatment, and prognosis for
septic arthritis (SA) in native joints differ signiﬁcantly
from those of PJIs, they suggested dividing the patients
into two separate groups. Furthermore, they suggested
differentiating between acute postoperative infections
and chronic PJIs. Unfortunately, we are not able to
differentiate between acute and chronic disease
because according to Danish law (the Data Protection
Agency), the data had been anonymized and therefore
we could not gain access to the medical records. The
descriptive and baseline characteristics of the patients
with a native joint infection versus patients with a PJI
are presented in Table 1.
Regarding our secondary outcomes (microbiological
aetiologies, systemic signs of inﬂammation, age, and
comorbidities), Dr Roerdink and Dr Dietvorst really
have a point because, according to Table 1, there is a
clear signiﬁcant difference between the two groups,
concerning age, systemic signs of inﬂammation [C-reac-
tive protein, white blood cell count (WBC), and tem-
perature], and the bacterial agent in synovial ﬂuid.
Coagulase-negative staphylococci are the main inhabi-
tants of normal skin and mucosal ﬂora, and have been
identiﬁed as the major nosocomial pathogen associated
with infections due to implanted medical devices, as a
result of their great bioﬁlm production capacity. There
are signiﬁcantly fewer infections caused by coagulase-
negative staphylococci in the patients with native joints
for this reason. On the other hand, two of the comorbid-
ities listed (diabetes mellitus and other inﬂammatory
diseases) are signiﬁcantly more frequent in the patients
with native joints. We did not ﬁnd any difference in the
30 day mortality between the two groups.
Finally, while we are grateful for the comments, we
would like to correct a misunderstanding. We did not
measure the WBC in the synovial ﬂuid, but in the peri-
pheral blood.
In conclusion, we agree on the importance of distinguish-
ing between SA in a native joint and an infection in a
prosthetic joint.
Table 1. Baseline data for patients presenting with septic arthritis (SA).
All Native joints PJIs p
N 215 114 101
Age (years), mean (sd) 64.8 (14.5) 62.5 (12.6) 67.4 (12.6) 0.012
Males, n (%) 142 (66.0) 86 (75.4) 56 (55.4) 0.002
Monoarticular SA, n (%) 208 (96.7) 109 (95.6) 99 (98.0) 0.28
Comorbidities, n (%)
Diabetes mellitus 24 (11.2) 18 (15.8) 6 (5.9) 0.018
Other inﬂammatory diseases* 24 (11.2) 21 (18.4) 3 (3.0) <0.001
Rheumatoid arthritis 22 (10.2) 11 (9.6) 11 (10.9) 0.47
Ischaemic heart disease 20 (9.3) 13 (11.4) 7 (6.9) 0.27
Liver disease 8 (3.7) 3 (2.6) 5 (5.0) 0.30
HIV 1 (0.5) 1 (0.9) 0 0.53
Died within 30 days 20 (9.3) 10 (8.8) 10 (9.9) 0.48
Paraclinical tests at presentation
CRP (mg/L)a 204 (133.1) 229.5 (131.9) 176.4 (129.4) 0.003
Temperature (°C)b 37.6 (0.90) 37.7 (0.98) 37.5 (0.79) 0.026
WBC x 109/Lc 11.9 (5.4) 13.0 (6.2) 10.6 (3.8) 0.001
Bacterial agents in synovial ﬂuid, n (%)
Staphylococcus aureus 104 (48.4) 62 (54.4) 42 (41.4) 0.003
Pyogenic streptococci 25 (11.6) 15 (13.2) 10 (10) 0.38
Coagulase-negative staphylococci† 27 (12.6) 4 (3.5) 23 (22.8) <0.001
Gram-negative rod-shaped bacteria 25 (11.6) 14 12.3) 11 (10.9) 0.48
Streptococcus mitis 21 9.8) 12 (10.5) 9 (8.9) 0.44
Other less common bacteria 13 (6.0) 6 (5.3) 7 (6.0) 0.41
PJI, periprosthetic joint infection; HIV, human immunodeﬁciency virus; CRP, C-reactive protein; WBC, white blood cell count.
*Gout, polymyalgia rheumatica, systemic lupus erythematosus, myositis.
†Including four cases with Staphylococcus lugdunensis.
aBased on 214 cases; bbased on 188 cases; cbased on 206 cases.
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